USE OF PROSTAGLANDIN E1, E2 OR ANALOGS TO PREVENT USE OF PROSTAGLANDIN E1, E2 OR ANALOGS TO PREVENT RENAL FAILURE INDUCED BY MEDICAL TESTS THAT UTILIZRENAL FAILURE INDUCED BY MEDICAL TESTS THAT UTILIZE CONTRAST MEDIA AGENTS E CONTRAST MEDIA AGENTS

摘要

A method of preventing renal failure or dysfunction caused by medical tests which utilize contrast media by administering, preferably by intravenous infusion or injection, a prostaglandin selected from PGE1, PGE2, PGI2 or an analog or pharmaceutically acceptable salt thereof and preferably in a form of a complex with alpha -cyclodextrin, to a patient at risk, for example, a diabetic.